Amezia Pharmaceutical Private Limited
About Amezia Pharmaceutical Private Limited
Data last updated:
Amezia Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2016PTC271686. Its GSTIN is 27AAOCA1124G1ZX (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Swapnal Dhanyakumar Doshi and Amit Mahadeo Pawar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 2 Ground Floor Om Vijaydeep Society Anand Nagar Badalapur East, Mumbai, Maharashtra, India – 421503.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.54 Lakh, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹24,490 (net margin 1%) and EBITDA of ₹1.87 Lakh (EBITDA margin 7.6%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Amezia Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No – 2 Ground Floor Om Vijaydeep Society Anand Nagar Badalapur East, Mumbai, Maharashtra, India – 421503
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Amezia Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amezia Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Amezia Pharmaceutical Private Limited, buy the company report.
Financials of Amezia Pharmaceutical Private Limited
FY 2025 filings availableAmezia Pharmaceutical Private Limited reported revenue of ₹24.54 Lakh (up 75% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 75% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,490 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amezia Pharmaceutical Private Limited, buy the company report.
Board of directors of Amezia Pharmaceutical Private Limited
Amezia Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnal Dhanyakumar Doshi | Director | 04 Mar 2021 | 5 Years 8 Months | Current |
| Amit Mahadeo Pawar | Director | 05 Jan 2016 | 10 Years 10 Months | Current |
Peer comparison
Amezia Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eldorex Pharmaceuticals Private Limited | ₹25.2 Lakh (FY 2025) | 149.0% | Thane, Maharashtra, India | |||
| Wilber Pharmaceutical Private Limited | ₹25.06 Lakh (FY 2025) | -29.0% | Delhi, India | |||
| Adigen Biogenesis Private Limited | ₹24.94 Lakh (FY 2025) | 352.0% | Kolkata, West Bengal, India | |||
| Derm Quest Private Limited | ₹24.67 Lakh (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Wondamed Pharmaceuticals Private Limited | ₹24.57 Lakh (FY 2025) | 16.0% | Jaipur, Rajasthan, India | |||
| Amezia Pharmaceutical Private Limitedthis company | ₹24.54 Lakh (FY 2025) | ₹24,490 | 1% | 75.0% | Mumbai, Maharashtra, India | |
| Merit Healthcare Private Limited | ₹24.51 Lakh (FY 2025) | -32.0% | Mumbai, Maharashtra, India | |||
| Sanlee Healthcare Private Limited | ₹24.41 Lakh (FY 2025) | 55.0% | Hyderabad, Telangana, India | |||
| Zealx Pharma Solutions Private Limited | ₹24.36 Lakh (FY 2025) | Karnal, Haryana, India | ||||
| Bonzer Packaging Private Limited | ₹24.33 Lakh (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Raybliss Pharma Private Limited | ₹24.21 Lakh (FY 2025) | Bangalore, Karnataka, India |
To see the full peer comparison of Amezia Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2016 | 100053146 | Bank of India | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Amezia Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amezia Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amezia Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCA1124G1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amezia Pharmaceutical Private Limited, buy the company report.
Recent activity
Amezia Pharmaceutical Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Swapnal Dhanyakumar Doshi ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Amezia Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2016 (10+ years old) and is registered under CIN U24233MH2016PTC271686.
Amezia Pharmaceutical has 2 current directors:
- Swapnal Dhanyakumar Doshi - Director
- Amit Mahadeo Pawar - Director
The latest financial statements of Amezia Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Amezia Pharmaceutical is 27AAOCA1124G1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Amezia Pharmaceutical is U24233MH2016PTC271686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amezia Pharmaceutical was incorporated on 05 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Amezia Pharmaceutical by revenue are Eldorex Pharmaceuticals Private Limited, Wilber Pharmaceutical Private Limited, Adigen Biogenesis Private Limited, Derm Quest Private Limited, Wondamed Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Swapnal Dhanyakumar Doshi ceased to be Additional Director on 30 Nov 2021. Punit Rajendrababu Bhandari ceased to be Director on 06 Mar 2021. Swapnal Dhanyakumar Doshi was appointed as Director on 04 Mar 2021. Amezia Pharmaceutical has 5 board changes on record in total.
The registered office of Amezia Pharmaceutical is at House No – 2 Ground Floor Om Vijaydeep Society Anand Nagar Badalapur East, Mumbai, Maharashtra, India – 421503.
Amezia Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Amezia Pharmaceutical has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
